Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis
dc.contributor.author | Baker, D | |
dc.date.accessioned | 2024-01-09T08:31:24Z | |
dc.date.available | 2023-12-21 | |
dc.date.available | 2024-01-09T08:31:24Z | |
dc.date.issued | 2023-12-21 | |
dc.identifier.issn | 2211-0356 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/93601 | |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Multiple Sclerosis and Related Disorders | |
dc.title | Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis | en_US |
dc.type | Article | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Accepted | en_US |
dcterms.dateAccepted | 2023-12-21 | |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |